Focus: Amber Therapeutics is a UK-based biotech company focused on neuromodulation therapy with a diversified pipeline spanning overactive bladder, spinal compression fractures, corneal disease, and allergic rhinitis. The company is early-stage with only 3 active job openings and operates across medical device and pharmaceutical modalities.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Amber Therapeutics is a high-risk, early-stage opportunity best suited for mission-driven scientists or operators comfortable with clinical uncertainty and limited near-term career progression.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Amber Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Amber Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo